Trade

with

Derma Sciences Inc
(NASDAQ: DSCI)
AdChoices
8.84
-0.09
-1.01%
After Hours :
-
-
-

Open

9.00

Previous Close

8.93

Volume (Avg)

7.47k (79.23k)

Day's Range

8.80-9.00

52Wk Range

7.88-15.51

Market Cap.

225.72M

Dividend Rate ( Yield )

-

Beta

1.08

Shares Outstanding

25.25M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 79.71M

    • Net Income

    • -23.96M

    • Market Cap.

    • 225.72M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -35.14

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.08

    • Forward P/E

    • -6.40

    • Price/Sales

    • 2.20

    • Price/Book Value

    • 1.56

    • Price/Cash flow

    • -7.80

      • EBITDA

      • -20.27M

      • Return on Capital %

      • -23.25

      • Return on Equity %

      • -25.47

      • Return on Assets %

      • -23.25

      • Book Value/Share

      • 5.74

      • Shares Outstanding

      • 25.25M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 17.88

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -1.42

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 15.30

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 9.69

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 36.86

            • 52.83

            • Pre-Tax Margin

            • -35.22

            • 15.96

            • Net Profit Margin

            • -35.14

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 32.20

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -12.50

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -12.10

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 12.84

              • 1.97

              • Quick Ratio

              • 10.58

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 1.08

              • 2.38

              • Book Value/Share

              • 5.74

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -6.24

                • 34.60

                • P/E Ratio 5-Year High

                • -10.89

                • 279.76

                • P/E Ratio 5-Year Low

                • -3.03

                • 148.87

                • Price/Sales Ratio

                • 2.19

                • 3.21

                • Price/Book Value

                • 1.55

                • 4.00

                • Price/Cash Flow Ratio

                • -7.80

                • 16.67

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -25.47

                    (-14.30)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • -23.25

                    (-11.80)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • -25.47

                    (-14.60)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • -

                  • 25.65k

                  • Inventory Turnover

                  • 3.33

                  • 2.66

                  • Asset Turnover

                  • 0.66

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -23.99M
                  Operating Margin
                  -30.10
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -7.80
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  67.64%

                  Mutual Fund Ownership

                  24.58%

                  Float

                  81.01%

                  5% / Insider Ownership

                  6.55%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • JPM Global Healthcare

                  •  

                    1,045,587

                  • 0.00

                  • 4.14

                  • Fidelity® Select Health Care Portfolio

                  •  

                    1,000,000

                  • 0.00

                  • 3.96

                  • JHancock Small Cap Core Fund

                  •  

                    428,493

                  • 0.00

                  • 1.70

                  • Fidelity® Select Medical Equip & Systems

                  •  

                    400,000

                  • 0.00

                  • 1.58

                  • Vanguard US Discoveries Fund

                  •  

                    354,912

                  • -9.07

                  • 1.41

                  • iShares Russell 2000 (AU)

                  •  

                    352,203

                  • -1.00

                  • 1.49

                  • Vanguard Total Stock Mkt Idx

                  •  

                    347,078

                  • 0.00

                  • 1.37

                  • Prudential Jennison Health Sciences

                  •  

                    225,180

                  • 0.00

                  • 0.89

                  • Fidelity Advisor® Health Care Fund

                  •  

                    212,595

                  • 0.00

                  • 0.84

                  • iShares Russell 2000 Value

                  •  

                    152,435

                  • 0.00

                  • 0.64

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Baker Bros Advisors LLC

                  •  

                    3,537,137

                  • 0.00%

                  • 14.02

                  • Fidelity Management and Research Company

                  •  

                    1,988,900

                  • -14.00%

                  • 7.88

                  • Broadfin Capital, LLC

                  •  

                    1,824,377

                  • +9.26%

                  • 7.23

                  • Consonance Capital Management LP

                  •  

                    1,451,692

                  • +62.83%

                  • 5.75

                  • Raging Capital Management LLC

                  •  

                    1,361,733

                  • +1.05%

                  • 8.12

                  • Great Point Partners LLC

                  •  

                    1,148,292

                  • +24.14%

                  • 4.55

                  • Jennison Associates LLC

                  •  

                    1,147,940

                  • -9.75%

                  • 4.55

                  • J P Morgan Asset Management (UK) Ltd

                  •  

                    1,045,587

                  • 0.00%

                  • 4.14

                  • 12 West Capital Management LP

                  •  

                    960,249

                  • 0.00%

                  • 5.73

                  • Camber Capital Management LLC

                  •  

                    950,000

                  • +26.67%

                  • 5.67

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Distressed

                  Style

                  Small Value

                  Derma Sciences Inc was incorporated on September 10, 1984. The Company is a tissue regeneration company engaged in three segments of the wound care marketplace: pharmaceutical wound care, advanced wound care and traditional wound car...moree products. The Company has one drug candidate that initiated its Phase 3 study. The Company maintains manufacturing facilities in Toronto, Canada and Nantong, China and an established network of third party suppliers for its products. Its products are sold through distributors to health care providers such as wound care centers, extended care facilities, acute care facilities, home health care agencies and physicians' offices. Some of its products are sold through retail channels to care givers. The Company markets its products through direct sales representatives in t...morehe United States, Canada and the United Kingdom, and through independent distributors within other select international markets. In Pharmaceutical Wound Care, the DSC127 product is in clinical trial for the treatment of diabetic foot ulcers. The Phase 3 clinical trial for diabetic foot ulcers is expected to be completed by the end of 2015. In addition to the diabetic foot ulcer indication, the Company has begun preclinical testing for scar reduction. The product lines in Advanced Wound Care include MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB, BIOGUARD, and ALGICELL AG. The Traditional Wound Care line consists of gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices. It also manufactures and market adhesive bandages and related first aid products for the medical, industrial, private label and retail markets. It markets a line of wound closure strips, nasal tube fasteners and a variety of catheter fasteners to doctors, clinics, nursing homes, hospitals and other institutions.lessless

                  Key People

                  Edward J. Quilty

                  CEO/Chairman of the Board/Director/President

                  John E. Yetter

                  CFO/Chief Accounting Officer/Executive VP, Divisional

                  Frederic Eigner

                  Executive VP, Divisional/General Manager, Subsidiary

                  Amy S. Paul

                  Director

                  C. Richard Stafford

                  Director

                  • Derma Sciences Inc

                  • 214 Carnegie Center

                  • Princeton, NJ 08540

                  • USA.Map

                  • Phone: +1 609 514-4744

                  • Fax: -

                  • dermasciences.com

                  Incorporated

                  1984

                  Employees

                  262

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: